Subject: File No. S7-08-09
From: Beth A Mathis

May 8, 2009

Why is Cell Genesys on life support today? The stock was knocked down to .09 in 2008 and trades today for .67. The destruction of a company that is developing immunotherapy cancer vaccines has been destroyed by your failure to stop the corruption. My hope as a cancer patient was for GVAX to be approved in 2008 but IMHO because of the enormous short position by hedge funds the FDA used the IDMC to blow-up the phase 3 trial. What a disgrace.